Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Elaboration and evaluation of a therapeutic education program in cancer pain management].
Prevost V, Clarisse B, Heutte N, Leconte A, Bisson C, Bignon R, Cauchin S, Feuillet M, Gehanne S, Gicquère M, Grach MC, Guillaumé C, Le Gal C, Le Garrec J, Lecaer F, Lepleux I, Millet AL, Ropartz MC, Roux N, Sep Hieng V, Van Delook C, Bechet C, Le Chevalier A, Delorme C. Prevost V, et al. Among authors: le gal c. Bull Cancer. 2018 Nov;105(11):1074-1083. doi: 10.1016/j.bulcan.2018.08.012. Epub 2018 Oct 14. Bull Cancer. 2018. PMID: 30327192 Free article. Review. French.
Therapeutic Patient Education in Cancer Pain Management: from Practice to Research: Proposals and Strategy of the French EFFADOL Program.
Prevost V, Clarisse B, Heutte N, Leconte A, Bisson C, Bignon R, Cauchin S, Feuillet M, Gehanne S, Gicquère M, Grach MC, Guillaumé C, Le Gal C, Le Garrec J, Lecaer F, Lepleux I, Millet AL, Ropartz MC, Roux N, Hieng VS, Van Delook C, Le Chevalier A, Delorme C. Prevost V, et al. Among authors: le gal c. J Cancer Educ. 2018 Dec;33(6):1355-1361. doi: 10.1007/s13187-017-1258-8. J Cancer Educ. 2018. PMID: 28804809
Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study.
Duvignaud A, Jaspard M, Etafo IC, Gabillard D, Serra B, Abejegah C, le Gal C, Abidoye AT, Doutchi M, Owhin S, Séri B, Vihundira JK, Bérerd-Camara M, Schaeffer J, Danet N, Augier A, Ogbaini-Emovon E, Salam AP, Ahmed LA, Duraffour S, Horby P, Günther S, Adedosu AN, Ayodeji OO, Anglaret X, Malvy D; LASCOPE study group. Duvignaud A, et al. Among authors: le gal c. Lancet Glob Health. 2021 Apr;9(4):e469-e478. doi: 10.1016/S2214-109X(20)30518-0. Lancet Glob Health. 2021. PMID: 33740408 Free PMC article.
HER2-Positive Breast Cancer Patients with Pre-Treatment Axillary Involvement or Postmenopausal Status Benefit from Neoadjuvant Rather than Adjuvant Chemotherapy Plus Trastuzumab Regimens.
Laas E, Bresset A, Féron JG, Le Gal C, Darrigues L, Coussy F, Grandal B, Laot L, Pierga JY, Reyal F, Hamy AS. Laas E, et al. Among authors: le gal c. Cancers (Basel). 2021 Jan 20;13(3):370. doi: 10.3390/cancers13030370. Cancers (Basel). 2021. PMID: 33498405 Free PMC article.
12 results